Litigation Details for Sanofi-Aventis U.S. LLC v. Mylan Pharmaceuticals Inc. (D. Del. 2017)
✉ Email this page to a colleague
Sanofi-Aventis U.S. LLC v. Mylan Pharmaceuticals Inc. (D. Del. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-01-09 |
| Court | District Court, D. Delaware | Date Terminated | 2018-01-01 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 6,794,410; 8,802,735; 9,186,346 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Sanofi-Aventis U.S. LLC v. Mylan Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Sanofi-Aventis U.S. LLC v. Mylan Pharmaceuticals Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-01-09 | 1 | infringement of United States Patent Nos. 6,794,410 (“the ‘410 patent,” a true and accurate copy of …United States Patent and Trademark Office granted reexamination certificate C1 6,794,410 for the ‘410 … INFRINGEMENT OF U.S. PATENT NO. 6,794,410 56. Plaintiffs repeat and reallege…INFRINGEMENT OF U.S. PATENT NO. 6,794,410 62. Plaintiffs repeat and reallege… THE PATENTS 20. The ‘410 patent, titled “Use of (Z)-2-cyano-3-hydroxy-but | External link to document | |
| 2017-01-09 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,794,410 C1; US 9,186,346 …2017 2 January 2018 1:17-cv-00024 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
